Marc A Pfeffer Selected Research

lixisenatide

1/2023	Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial.
1/2022	Risk Estimates of Imminent Cardiovascular Death and Heart Failure Hospitalization Are Improved Using Serial Natriuretic Peptide Measurements in Patients With Coronary Artery Disease and Type 2 Diabetes.
1/2022	Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study.
10/2020	Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial.
1/2018	Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration.
1/2016	Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.
12/2015	Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
5/2015	Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc A Pfeffer Research Topics

Disease

229	Heart Failure 03/2024 - 04/2003
96	Myocardial Infarction 03/2024 - 02/2003
36	Stroke (Strokes) 10/2023 - 04/2003
35	Left Ventricular Dysfunction 03/2024 - 08/2003
35	Chronic Renal Insufficiency 11/2022 - 09/2004
34	Type 2 Diabetes Mellitus (MODY) 01/2023 - 04/2003
26	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 04/2002
21	Acute Coronary Syndrome 01/2023 - 04/2004
20	Atrial Fibrillation 01/2023 - 05/2005
20	Anemia 04/2022 - 01/2005
19	Chronic Kidney Failure (Chronic Renal Failure) 10/2023 - 04/2003
15	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 09/2003
14	Hypotension (Low Blood Pressure) 03/2024 - 09/2003
14	Coronary Disease (Coronary Heart Disease) 01/2020 - 03/2002
13	Heart Arrest (Cardiac Arrest) 11/2021 - 09/2004
13	Hyperkalemia 01/2021 - 10/2004
12	Diabetes Mellitus 12/2022 - 07/2004
11	Hypertension (High Blood Pressure) 01/2023 - 06/2002
7	Inflammation (Inflammations) 01/2024 - 11/2004
7	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 03/2009
7	Heart Diseases (Heart Disease) 10/2023 - 01/2004
7	Sudden Death 12/2021 - 10/2004
6	Cardiomyopathies (Cardiomyopathy) 10/2023 - 03/2015
5	Fibrosis (Cirrhosis) 01/2023 - 01/2004
5	Albuminuria 11/2018 - 11/2004
5	Proteinuria 02/2013 - 07/2009
4	Renal Insufficiency (Renal Failure) 10/2023 - 01/2007
4	Infarction (Infarctions) 01/2023 - 09/2004
4	Systolic Heart Failure 04/2022 - 03/2013
4	Hypokalemia 01/2019 - 04/2014
4	Neoplasms (Cancer) 04/2013 - 05/2002
4	Diabetic Nephropathies (Diabetic Nephropathy) 07/2005 - 04/2003
3	ST Elevation Myocardial Infarction 03/2024 - 01/2021
3	Dyspnea (Shortness of Breath) 01/2024 - 10/2019
3	Respiratory Sounds (Crackle) 11/2022 - 01/2019
3	Edema (Dropsy) 01/2021 - 01/2019
3	Fatigue 01/2021 - 11/2009
3	Unstable Angina 12/2015 - 04/2004
3	Hemorrhage 09/2009 - 07/2004
3	Vascular Diseases (Vascular Disease) 05/2006 - 11/2004

Drug/Important Bio-Agent (IBA)

55	candesartanIBA 08/2021 - 09/2003
50	Valsartan (Vals)FDA Link 03/2024 - 08/2003
47	Mineralocorticoid Receptor AntagonistsIBA 11/2023 - 10/2004
42	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2024 - 06/2002
34	sacubitril and valsartan sodium hydrate drug combinationIBA 03/2024 - 01/2017
33	CreatinineIBA 11/2022 - 04/2003
28	Spironolactone (Aldactone)FDA LinkGeneric 01/2023 - 11/2007
25	paragonIBA 03/2024 - 01/2017
25	Darbepoetin alfa (Aranesp)FDA Link 04/2022 - 03/2005
23	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2016 - 08/2003
18	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2023 - 07/2007
18	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2007
18	Angiotensin Receptor AntagonistsIBA 12/2021 - 04/2003
17	Irbesartan FDA LinkGeneric 01/2023 - 04/2003
16	Hemoglobins (Hemoglobin)IBA 01/2019 - 02/2006
15	Neprilysin (Neutral Endopeptidase)IBA 11/2023 - 06/2002
13	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2023 - 08/2003
13	pro-brain natriuretic peptide (1-76)IBA 10/2023 - 07/2007
13	Natriuretic PeptidesIBA 01/2023 - 06/2002
12	Captopril (Capoten)FDA LinkGeneric 06/2016 - 08/2003
11	aliskiren FDA Link 10/2020 - 05/2009
10	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 04/2002
10	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2021 - 04/2002
9	Pravastatin (Pravachol)FDA LinkGeneric 03/2008 - 03/2002
8	Insulin (Novolin)FDA Link 01/2023 - 09/2004
8	lixisenatideIBA 01/2023 - 05/2015
8	trandolapril (Mavik)FDA LinkGeneric 01/2019 - 11/2004
8	AlbuminsIBA 01/2019 - 11/2004
7	Ramipril (Altace)FDA LinkGeneric 03/2024 - 11/2021
7	DiureticsIBA 01/2023 - 07/2010
7	PotassiumIBA 01/2023 - 11/2007
7	AngiotensinsIBA 09/2022 - 07/2005
7	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 04/2003
7	Troponin T (Troponin T1)IBA 01/2021 - 12/2009
6	C-Reactive ProteinIBA 01/2024 - 08/2006
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2003
5	ReninIBA 01/2021 - 07/2005
5	HematinicsIBA 01/2019 - 07/2009
4	Enalapril FDA LinkGeneric 09/2022 - 06/2002
4	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 07/2005
4	LDL CholesterolIBA 03/2019 - 03/2002
4	Renin InhibitorsIBA 06/2016 - 05/2009
4	Clopidogrel (Plavix)FDA Link 03/2015 - 11/2007
4	HomocysteineIBA 04/2011 - 11/2004
3	dalcetrapibIBA 12/2022 - 01/2020
3	Eplerenone (Inspra)FDA LinkGeneric 11/2022 - 01/2018
3	Trinitrotoluene (TNT)IBA 01/2021 - 11/2011
3	Angiotensin IIIBA 11/2020 - 03/2006
3	AnticoagulantsIBA 01/2016 - 09/2009
3	Simvastatin (Zocor)FDA LinkGeneric 11/2009 - 09/2004
3	Tirofiban (Aggrastat)FDA Link 11/2009 - 07/2004
3	Atorvastatin (Lipitor)FDA Link 10/2005 - 04/2004

Therapy/Procedure

83	Therapeutics 01/2023 - 02/2003
7	Cardiac Resynchronization Therapy 05/2014 - 10/2009
5	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 10/2019 - 08/2010
4	Transplantation 10/2023 - 04/2011
4	Secondary Prevention 01/2023 - 09/2003
4	Resuscitation 12/2012 - 09/2004
3	Kidney Transplantation 10/2023 - 10/2017
3	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2017 - 11/2011